Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,033 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial.
Abramson JS, Ku M, Hertzberg M, Huang HQ, Fox CP, Zhang H, Yoon DH, Kim WS, Abdulhaq H, Townsend W, Herbaux C, Zaucha JM, Zhang QY, Chang H, Liu Y, Cheah CY, Ghesquieres H, Simko S, Orellana-Noia V, Ta R, Relf J, Dixon M, Kallemeijn M, Mulvihill E, Huang H, Lundberg L, Gregory GP. Abramson JS, et al. Among authors: fox cp. Lancet. 2024 Nov 16;404(10466):1940-1954. doi: 10.1016/S0140-6736(24)01774-4. Lancet. 2024. PMID: 39550172 Clinical Trial.
Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial.
Werring DJ, Dehbi HM, Ahmed N, Arram L, Best JG, Balogun M, Bennett K, Bordea E, Caverly E, Chau M, Cohen H, Cullen M, Doré CJ, Engelter ST, Fenner R, Ford GA, Gill A, Hunter R, James M, Jayanthi A, Lip GYH, Massingham S, Murray ML, Mazurczak I, Nash PS, Ndoutoumou A, Norrving B, Sims H, Sprigg N, Vanniyasingam T, Freemantle N; OPTIMAS investigators. Werring DJ, et al. Lancet. 2024 Oct 23:S0140-6736(24)02197-4. doi: 10.1016/S0140-6736(24)02197-4. Online ahead of print. Lancet. 2024. PMID: 39491870 Free article.
Exploring yeast glucans for vaccine enhancement: Sustainable strategies for overcoming adjuvant challenges in a SARS-CoV-2 model.
Azevedo-Silva J, Amorim M, Tavares-Valente D, Sousa P, Mohamath R, Voigt EA, Guderian JA, Kinsey R, Viana S, Reis F, Pintado ME, Paddon CJ, Fox CB, Fernandes JC. Azevedo-Silva J, et al. Among authors: fox cb. Eur J Pharm Biopharm. 2024 Oct 24:114538. doi: 10.1016/j.ejpb.2024.114538. Online ahead of print. Eur J Pharm Biopharm. 2024. PMID: 39461571 Free article.
Adult emergency resuscitative thoracotomy: A Western Trauma Association clinical decisions algorithm.
Tesoriero R, Coimbra R, Biffl WL, Burlew CC, Croft CA, Fox C, Hartwell JL, Keric N, Lorenzo M, Martin MJ, Magee GA, Moore LJ, Privette AR, Schellenberg M, Schuster KM, Weinberg JA, Stein DM. Tesoriero R, et al. Among authors: fox c. J Trauma Acute Care Surg. 2024 Oct 25. doi: 10.1097/TA.0000000000004462. Online ahead of print. J Trauma Acute Care Surg. 2024. PMID: 39451159 No abstract available.
Cost-utility analysis of adapted problem adaptation therapy for depression in mild-to-moderate dementia caused by Alzheimer's disease: PATHFINDER randomised controlled trial.
Panca M, Howard R, Cort E, Rawlinson C, Gould RL, Wiegand M, Downey AM, Banerjee S, Fox C, Harwood R, Livingston G, Moniz-Cook E, Russell G, Thomas A, Wilkinson P, Freemantle N, Hunter RM. Panca M, et al. Among authors: fox c. BJPsych Open. 2024 Oct 25;10(6):e189. doi: 10.1192/bjo.2024.775. BJPsych Open. 2024. PMID: 39450544 Free article.
3,033 results